CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • Contributers

Recommended Insights

Factors to Employ Whilst Evaluating a...

Shahin Farshchi, Partner, Lux Capital

Recent Trends In The Startup Landscape

Al Sambar, General Partner, XRC Labs

Brave New World - A Glance at the Startup...

Sam Colella, VC, Versant Ventures

The Changing Geography of the Venture Capital

Fernando Rivera, Managing Partner, BuenTrip Ventures

The Importance of Being an Active Investor

Glenn Rieger, General Partner, NewSpring Capital

Intricacies of Precision Medicine

Andrew Garrett, PhD, Executive Vice President,...

How Recent Technology Transformations In...

Silji Abraham, Senior Vice President & Chief Digital...

Iot - Back To The Past - And Into Last...

Dov Moran, Managing Partner, Grove Ventures

Factors to Employ Whilst Evaluating a...

Shahin Farshchi, Partner, Lux Capital

Recent Trends In The Startup Landscape

Al Sambar, General Partner, XRC Labs

Brave New World - A Glance at the Startup...

Sam Colella, VC, Versant Ventures

The Changing Geography of the Venture Capital

Fernando Rivera, Managing Partner, BuenTrip Ventures

The Importance of Being an Active Investor

Glenn Rieger, General Partner, NewSpring Capital

Intricacies of Precision Medicine

Andrew Garrett, PhD, Executive Vice President,...

How Recent Technology Transformations In...

Silji Abraham, Senior Vice President & Chief Digital...

Iot - Back To The Past - And Into Last...

Dov Moran, Managing Partner, Grove Ventures

Startups In The Coronavirus Era: The Acceleration Of Online Fundraising

Tai Nicolopoulos, Head of Marketing, SeedInvest
Tweet

Over the past decade, there has been an accelerating, long-term shift in most types of commerce and consumption moving online, and COVID-19 seems to be a catalyst to accelerating this shift. At SeedInvest, an equity crowdfunding platform which has successfully funded over 200 companies since its inception, we polled founders to gain a deeper understanding of how startups are responding to COVID-19, and how the economic climate resulting from this crisis has impacted their plans to deploy and raise capital.


Our main takeaway is that COVID-19 has slowed, but not stopped fundraising efforts, and has led founders to consider more alternatives to traditional venture capital. Below are highlights from the results of this survey.


Who are our respondents?


● Out of the 70 startup founders who participated, 28% are international, 22% are based on the West Coast, 15% are based on the East Coast, another 15% are based in the South, and the remainder are spread across the Midwest.


● The companies also fall across a wide range of industries, with the top represented sectors being: healthcare (19%), technology (19%), B2B SaaS (10%), and Entertainment (8%).


● The participating companies range from pre-seed to Series C, with a median $5.7 mm in total capital raised.


The majority of respondents are either raising capital or will be soon.


● 36% of respondents are currently fundraising, an additional 22% are looking to raise in the next three months, and a further, 18% are looking to raise in the next six months.


COVID-19 is causing founders to consider alternative sources of funding:


● 60% of founders said they were more likely to raise from a new investor or investors with whom they had not worked previously.


● 44% of founders said that COVID-19 made them more likely to consider online equity crowdfunding platforms for their next raise, vs. 52% who were no more or less likely to consider it, and 4% who said they were less likely to consider it.


Fundraising is happening remotely, but a personal connection with investors still matters.


● The three most popular tools with participating founders were personal emails, phone calls, and Video Conferencing, with founders stating their experiences fundraising with these tools had been, on average, “Quite Positive” (8 out of 10). Meanwhile, their experiences with “cold” or mass emails, webinars, syndicates, and unsolicited outreach via LinkedIn had been “Quite Negative” (2 out of 10) on average.


"Our main takeaway is that COVID-19 has slowed, but not stopped fundraising efforts, and has led founders to consider more alternatives to traditional venture capital"


Investment is still occurring, albeit a little more slowly.


● 48% of founders said that investors were just as responsive as before. Meanwhile, 37% said they were less responsive, and just 15% said investors were more responsive.


● 44% of founders said they are delaying or previously delayed a raise because of COVID- 19, vs. 23% who are accelerating the timeline of an upcoming raise.


In the COVID-19 era, remote working is here to stay, as is remote investing. In fact, pitching to investors or finding a crowd funding platform to help fund your business may be easier and more accessible than ever. With offices closed, founders no longer need to physically travel to tech hubs such as Silicon Valley to pitch their business idea. This larger secular shift that is moving traditional startup fundraising and investing online could be the new normal.


Weekly Brief

loading
Top 10 Biotech Startups Companies - 2022
> <
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2021

    Top Vendors

    Current Issue
  • BioTech Startups 2022

    Top Vendors

    Current Issue
  • BioTech Startups 2021

    Top Vendors

    Current Issue

Read Also

Achieving trial master file quality, timeliness and completeness

Susan K. Maue, Designation : Managing Director PharmaLex

Antibodies: The Building Blocks of Cures

John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma

The Dynamic Commercial Aspects of Life Sciences

Jim Cooper, Director, Clinical Operations, Moderna

The Future of Life Sciences Industry

Matthew (Matt) Hewitt, Executive Director, Scientific Solutions C and GT, Charles River

Accelerating Digital Transformation through an Agile, Customer-centric Approach

Mark Mintz, Chief Information Officer at Charles River Laboratories

Re-imagining Learning in a Post-Pandemic World

Sebastian Teo, Head of Learning & Talent Management, Linde

Gene Therapy Clearly Communicated: The Importance of Patient-Centricity, Anan Omnichannel Approach, and Health Literacy

Tara Moroz, PhD Sr. Director, Genetic Medicine and Early Pipeline, Pfizer Inc.

Discovering the Medicines of the Future

Araz Raoof, Senior Vice President Global Drug Discovery & External Innovation at Ferring Pharmaceuticals
Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-startups.lifesciencesreview.com/cxoinsight/startups-in-the-coronavirus-era-the-acceleration-of-online-fundraising-nwid-419.html